TY - JOUR AU - Tameris, M. D. AU - Hatherill, M. AU - Landry, B. S. AU - Scriba, T. J. AU - Snowden, M. A. AU - Lockhart, S. AU - Shea, J. E. AU - McClain, J. B. AU - Hussey, G. D. AU - Hanekom, W. A. AU - Mahomed, H. AU - McShane, H. PY - 2013 DA - 2013// TI - Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial JO - Lancet VL - 381 UR - https://doi.org/10.1016/S0140-6736(13)60177-4 DO - 10.1016/S0140-6736(13)60177-4 ID - Tameris2013 ER - TY - STD TI - Zak DE, Penn-Nicholson A*, Scriba TJ, Thompson E, Suliman S, Amon LM, Mahomed H, Erasmus M, Whatney W, Hussey GD., Abrahams D, Kafaar F, Hawkridge T, Verver S, Hughes J, Ota M, Sutherland J, Howe R, Dockrell HM, Boom WH., Thiel B, Ottenhoff THM, Mayanja-Kizza H, Crampin AC, Downing K, Hatherill M, Valvo J, Shankar S, Parida SK, Kaufmann SHE., Walzl G, Aderem A, Hanekom WA, for other members of the ACS and GC6-74 cohort study teams. A prospective blood RNA signature for tuberculosis disease risk. Lancet. In Press. ID - ref2 ER - TY - STD TI - Fletcher HA, Snowden MA, Landry B, Rida W, Satti I, Harris SA, Matsumiya M, Tanner R, O’Shea MK, Dheenadhayalan V, Bogardus L, Stockdale L, Marsay L, Chomka A, Harrington-Kandt R, Thomas Z-RM, Naranbhai V, Stylianou E, Darboe F, Penn-Nicholson A, Nemes E, Hatheril M, Hussey G, Mahomed H, Tameris M, McClain JB, Evans TG, Hanekom WA, Scriba TJ, McShane H. T cell activation is an Immune Correlate of Risk in BCG vaccinated infants. Nature Communications. In Press ID - ref3 ER - TY - JOUR AU - Gillespie, S. H. AU - Crook, A. M. AU - McHugh, T. D. AU - Mendel, C. M. AU - Meredith, S. K. AU - Murray, S. R. AU - Pappas, F. AU - Phillips, P. P. AU - Nunn, A. J. PY - 2014 DA - 2014// TI - the REMoxTB Consortium. Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1407426 DO - 10.1056/NEJMoa1407426 ID - Gillespie2014 ER - TY - JOUR AU - Jindani, A. AU - Harrison, T. S. AU - Nunn, A. J. AU - Phillips, P. P. AU - Churchyard, G. J. AU - Charalambous, S. AU - Hatherill, M. AU - Geldenhuys, H. AU - McIlleron, H. M. AU - Zvada, S. P. PY - 2014 DA - 2014// TI - High-dose rifapentine with moxifloxacin for pulmonary tuberculosis JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1314210 DO - 10.1056/NEJMoa1314210 ID - Jindani2014 ER - TY - JOUR AU - Merle, C. S. AU - Fielding, K. AU - Sow, O. B. AU - Gninafon, M. AU - Lo, M. B. AU - Mthiyane, T. AU - Odhiambo, J. AU - Amukoye, E. AU - Bah, B. AU - Kassa, F. PY - 2014 DA - 2014// TI - A four-month gatifloxacin-containing regimen for treating tuberculosis JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1315817 DO - 10.1056/NEJMoa1315817 ID - Merle2014 ER - TY - STD TI - Siroka A, Ponce NA, Lönnroth K. Association between spending on social protection and tuberculosis burden: a global analysis. [Epub ahead of print] Lancet Infect Dis. 2015. doi: 10.1016/S1473-3099(15)00401-6. ID - ref7 ER - TY - JOUR AU - Yates, T. A. AU - Khan, P. Y. AU - Knight, G. M. AU - Taylor, J. G. AU - McHugh, T. D. AU - Lipman, M. AU - White, R. G. AU - Cohen, T. AU - Cobelens, F. G. AU - Wood, R. AU - Moore, D. A. AU - Abubakar, I. PY - 2016 DA - 2016// TI - The transmission of Mycobacterium tuberculosis in high burden settings JO - Lancet Infect Dis VL - 16 UR - https://doi.org/10.1016/S1473-3099(15)00499-5 DO - 10.1016/S1473-3099(15)00499-5 ID - Yates2016 ER - TY - STD TI - WHO End TB Strategy http://www.who.int/tb/End_TB_brochure.pdf. Accessed 5 Mar 2016. UR - http://www.who.int/tb/End_TB_brochure.pdf ID - ref9 ER -